These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 18668225)

  • 1. SSR149415, a non-peptide vasopressin V1b receptor antagonist, has long-lasting antidepressant effects in the olfactory bulbectomy-induced hyperactivity depression model.
    Breuer ME; van Gaalen MM; Wernet W; Claessens SE; Oosting RS; Behl B; Korte SM; Schoemaker H; Gross G; Olivier B; Groenink L
    Naunyn Schmiedebergs Arch Pharmacol; 2009 Jan; 379(1):101-6. PubMed ID: 18668225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term behavioral changes after cessation of chronic antidepressant treatment in olfactory bulbectomized rats.
    Breuer ME; Groenink L; Oosting RS; Westenberg HG; Olivier B
    Biol Psychiatry; 2007 Apr; 61(8):990-5. PubMed ID: 17141743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An arginine vasopressin V1b antagonist, SSR149415 elicits antidepressant-like effects in an olfactory bulbectomy model.
    Iijima M; Chaki S
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):622-7. PubMed ID: 17229509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders.
    Griebel G; Simiand J; Serradeil-Le Gal C; Wagnon J; Pascal M; Scatton B; Maffrand JP; Soubrie P
    Proc Natl Acad Sci U S A; 2002 Apr; 99(9):6370-5. PubMed ID: 11959912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressant effects of pramipexole, a dopamine D3/D2 receptor agonist, and 7-OH-DPAT, a dopamine D3 receptor agonist, in olfactory bulbectomized rats.
    Breuer ME; Groenink L; Oosting RS; Buerger E; Korte M; Ferger B; Olivier B
    Eur J Pharmacol; 2009 Aug; 616(1-3):134-40. PubMed ID: 19549514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-peptide vasopressin V1b receptor antagonists as potential drugs for the treatment of stress-related disorders.
    Griebel G; Stemmelin J; Gal CS; Soubrié P
    Curr Pharm Des; 2005; 11(12):1549-59. PubMed ID: 15892661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that the lateral septum is involved in the antidepressant-like effects of the vasopressin V1b receptor antagonist, SSR149415.
    Stemmelin J; Lukovic L; Salome N; Griebel G
    Neuropsychopharmacology; 2005 Jan; 30(1):35-42. PubMed ID: 15367924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant-like effects of the vasopressin V1b receptor antagonist SSR149415 in the Flinders Sensitive Line rat.
    Overstreet DH; Griebel G
    Pharmacol Biochem Behav; 2005 Sep; 82(1):223-7. PubMed ID: 16181667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview of SSR149415, a selective nonpeptide vasopressin V(1b) receptor antagonist for the treatment of stress-related disorders.
    Serradeil-Le Gal C; Wagnon J; Tonnerre B; Roux R; Garcia G; Griebel G; Aulombard A
    CNS Drug Rev; 2005; 11(1):53-68. PubMed ID: 15867952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential roles of amygdaloid nuclei in the anxiolytic- and antidepressant-like effects of the V1b receptor antagonist, SSR149415, in rats.
    Salomé N; Stemmelin J; Cohen C; Griebel G
    Psychopharmacology (Berl); 2006 Aug; 187(2):237-44. PubMed ID: 16779555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the vasopressin (V1b) receptor antagonist, SSR149415, and the corticotropin-releasing factor 1 receptor antagonist, SSR125543, on FG 7142-induced increase in acetylcholine and norepinephrine release in the rat.
    Claustre Y; Rouquier L; Desvignes C; Leonetti M; Montégut J; Aubin N; Allouard N; Bougault I; Oury-Donat F; Steinberg R
    Neuroscience; 2006 Sep; 141(3):1481-8. PubMed ID: 16781820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant and anxiolytic profiles of newly synthesized arginine vasopressin V1B receptor antagonists: TASP0233278 and TASP0390325.
    Iijima M; Yoshimizu T; Shimazaki T; Tokugawa K; Fukumoto K; Kurosu S; Kuwada T; Sekiguchi Y; Chaki S
    Br J Pharmacol; 2014 Jul; 171(14):3511-25. PubMed ID: 24654684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of newly synthesized 1,2,4-triazino[5,6-b]indole-3-thione derivatives on olfactory bulbectomy induced depression in rats.
    Aswar UM; Kalshetti PP; Shelke SM; Bhosale SH; Bodhankar SL
    Asian Pac J Trop Biomed; 2012 Dec; 2(12):992-8. PubMed ID: 23593581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The vasopressin V1b receptor as a therapeutic target in stress-related disorders.
    Griebel G; Simiand J; Stemmelin J; Gal CS; Steinberg R
    Curr Drug Targets CNS Neurol Disord; 2003 Jun; 2(3):191-200. PubMed ID: 12769799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant-like effects of the delta-opioid receptor agonist SNC80 ([(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in an olfactory bulbectomized rat model.
    Saitoh A; Yamada M; Yamada M; Takahashi K; Yamaguchi K; Murasawa H; Nakatani A; Tatsumi Y; Hirose N; Kamei J
    Brain Res; 2008 May; 1208():160-9. PubMed ID: 18381208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmental enrichment has antidepressant-like action without improving learning and memory deficits in olfactory bulbectomized rats.
    Hendriksen H; Meulendijks D; Douma TN; Bink DI; Breuer ME; Westphal KG; Olivier B; Oosting RS
    Neuropharmacology; 2012 Jan; 62(1):270-7. PubMed ID: 21807004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral changes induced through adenosine A2A receptor ligands in a rat depression model induced by olfactory bulbectomy.
    Padilla KM; Quintanar-Setephano A; López-Vallejo F; Berumen LC; Miledi R; García-Alcocer G
    Brain Behav; 2018 May; 8(5):e00952. PubMed ID: 29761007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of arginine vasopressin and V1b receptor in alcohol drinking in Sardinian alcohol-preferring rats.
    Zhou Y; Colombo G; Carai MA; Ho A; Gessa GL; Kreek MJ
    Alcohol Clin Exp Res; 2011 Oct; 35(10):1876-83. PubMed ID: 21575018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agomelatine suppresses locomotor hyperactivity in olfactory bulbectomised rats: a comparison to melatonin and to the 5-HT(2c) antagonist, S32006.
    Norman TR; Cranston I; Irons JA; Gabriel C; Dekeyne A; Millan MJ; Mocaër E
    Eur J Pharmacol; 2012 Jan; 674(1):27-32. PubMed ID: 22040921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressant-like effects of the corticotropin-releasing factor 1 receptor antagonist, SSR125543, and the vasopressin 1b receptor antagonist, SSR149415, in a DRL-72 s schedule in the rat.
    Louis C; Cohen C; Depoortère R; Griebel G
    Neuropsychopharmacology; 2006 Oct; 31(10):2180-7. PubMed ID: 16452986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.